Smithkline Beecham Pharma Inc. v. Apotex Inc., 2002 CAF 216 (2002)

Federal Court of Appeal

Linked as:

Extract


Smithkline Beecham Pharma Inc. v. Apotex Inc., 2002 CAF 216 (2002)

Federal Court Reports

SmithKline Beecham Pharma Inc. v. Apotex Inc. (C.A.) [2003] 1 F.C. 118

Date: 20020528

Docket: A-422-01

Neutral citation: 2002 FCA 216

CORAM: LINDEN J.A.

EVANS J.A.

MALONE J.A.

BETWEEN:

SMITHKLINE BEECHAM PHARMA INC.

and

BEECHAM GROUP P.L.C.

Appellants

(Applicants)

and

APOTEX INC.

and

THE MINISTER OF HEALTH

Respondents

(Respondents)

Heard at Toronto, Ontario, on Thursday, May 9, 2002.

Judgment delivered at Ottawa, Ontario, on Tuesday, May 28, 2002

REASONS FOR JUDGMENT BY: LINDEN J.A.

CONCURRED IN BY: EVANS J.A.

MALONE J.A.

Date: 20020528

Docket: A-422-01

Neutral citation: 2002 FCA 216

CORAM: LINDEN J.A.

EVANS J.A.

MALONE J.A.

BETWEEN:

SMITHKLINE BEECHAM PHARMA INC.

and

BEECHAM GROUP P.L.C.

Appellants

(Applicants)

and

APOTEX INC.

and

THE MINISTER OF HEALTH

Respondents

(Respondents)

REASONS FOR JUDGMENT

LINDEN J.A.

INTRODUCTION

[1] This is an appeal from an order of Gibson J. (the "Applications Judge") in which he dismissed an application brought pursuant to subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations , SOR/98 - 166, (the " Regulations &quot...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex Canada

Explore vLex

For Professionals

For Partners

Company